{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:55:11Z","timestamp":1781373311960,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00415-026-13899-7","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:58:51Z","timestamp":1780293531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of probiotic medication use with incident Parkinson disease and alzheimer disease: a nationwide nested case\u2013control study"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-6328","authenticated-orcid":false,"given":"Yasutaka","family":"Ihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Miyaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"4","key":"13899_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(4):344\u2013381","journal-title":"Lancet Neurol"},{"issue":"11","key":"13899_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939\u2013953","journal-title":"Lancet Neurol"},{"issue":"1","key":"13899_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"GBD 2016 Dementia Collaborators","year":"2019","unstructured":"GBD 2016 Dementia Collaborators (2019) Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(1):88\u2013106","journal-title":"Lancet Neurol"},{"key":"13899_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"issue":"5","key":"13899_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI205275","volume":"136","author":"B Palushaj","year":"2026","unstructured":"Palushaj B, Voigt RM (2026) The Parkinson\u2019s pandemic: prioritizing environmental policy and biological resilience via the gut. J Clin Invest 136(5):e205275. https:\/\/doi.org\/10.1172\/JCI205275","journal-title":"J Clin Invest"},{"issue":"6","key":"13899_CR6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469-1480.e12. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","journal-title":"Cell"},{"issue":"1","key":"13899_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA et al (2017) Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep 7(1):13537. https:\/\/doi.org\/10.1038\/s41598-017-13601-y","journal-title":"Sci Rep"},{"issue":"3","key":"13899_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ana.26719","volume":"94","author":"N Palacios","year":"2023","unstructured":"Palacios N, Wilkinson J, Bjornevik K et al (2023) Metagenomics of the gut microbiome in Parkinson\u2019s disease: prodromal changes. Ann Neurol 94(3):486\u2013501. https:\/\/doi.org\/10.1002\/ana.26719","journal-title":"Ann Neurol"},{"issue":"9","key":"13899_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108807","volume":"34","author":"D Rosario","year":"2021","unstructured":"Rosario D, Bidkhori G, Lee S et al (2021) Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson\u2019s disease. Cell Rep 34(9):108807. https:\/\/doi.org\/10.1016\/j.celrep.2021.108807","journal-title":"Cell Rep"},{"issue":"5","key":"13899_CR10","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1212\/WNL.0000000000010998","volume":"96","author":"AH Tan","year":"2021","unstructured":"Tan AH, Lim SY, Chong KK et al (2021) Probiotics for constipation in Parkinson disease: a randomized placebo-controlled study. Neurology 96(5):e772\u2013e782. https:\/\/doi.org\/10.1212\/WNL.0000000000010998","journal-title":"Neurology"},{"issue":"3","key":"13899_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/jgf2.422","volume":"22","author":"K Nagai","year":"2021","unstructured":"Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T (2021) Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med 22(3):118\u2013127. https:\/\/doi.org\/10.1002\/jgf2.422","journal-title":"J Gen Fam Med"},{"issue":"4","key":"13899_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.6865","volume":"7","author":"M Takeshima","year":"2024","unstructured":"Takeshima M, Yoshizawa K, Ogasawara M et al (2024) Treatment failure and long-term prescription risk for guideline-recommended hypnotics in Japan. JAMA Netw Open 7(4):e246865. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.6865","journal-title":"JAMA Netw Open"},{"issue":"10","key":"13899_CR13","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.cgh.2024.04.035","volume":"22","author":"A Sawada","year":"2024","unstructured":"Sawada A, Imai T, Ihara Y, Tanaka F, Hirano I, Fujiwara Y (2024) Epidemiology and risk factors of eosinophilic esophagitis in Japan: a population-based study. Clin Gastroenterol Hepatol 22(10):2023-2032.e6. https:\/\/doi.org\/10.1016\/j.cgh.2024.04.035","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"17","key":"13899_CR14","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1161\/CIRCULATIONAHA.120.047873","volume":"142","author":"H Ohbe","year":"2020","unstructured":"Ohbe H, Goto T, Miyamoto Y, Yasunaga H (2020) Risk of cardiovascular events after spouse\u2019s ICU admission. Circulation 142(17):1691\u20131693. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047873","journal-title":"Circulation"},{"issue":"1","key":"13899_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00523-y","volume":"9","author":"C Pearson","year":"2023","unstructured":"Pearson C, Hartzman A, Munevar D et al (2023) Care access and utilization among Medicare beneficiaries living with Parkinson\u2019s disease. NPJ Park Dis 9(1):108. https:\/\/doi.org\/10.1038\/s41531-023-00523-y","journal-title":"NPJ Park Dis"},{"issue":"5","key":"13899_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/ane.12694","volume":"136","author":"M Nerius","year":"2017","unstructured":"Nerius M, Fink A, Doblhammer G (2017) Parkinson\u2019s disease in Germany: prevalence and incidence based on health claims data. Acta Neurol Scand 136(5):386\u2013392. https:\/\/doi.org\/10.1111\/ane.12694","journal-title":"Acta Neurol Scand"},{"key":"13899_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2020.100061","volume":"3","author":"BJ Peterson","year":"2020","unstructured":"Peterson BJ, Rocca WA, Bower JH, Savica R, Mielke MM (2020) Identifying incident Parkinson\u2019s disease using administrative diagnostic codes: a validation study. Clin Parkinsonism Relat Disord 3:100061. https:\/\/doi.org\/10.1016\/j.prdoa.2020.100061","journal-title":"Clin Parkinsonism Relat Disord"},{"key":"13899_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.611446","volume":"12","author":"MS Baek","year":"2021","unstructured":"Baek MS, Han K, Kwon HS, Lee YH, Cho H, Lyoo CH (2021) Risks and prognoses of Alzheimer\u2019s disease and vascular dementia in patients with insomnia: a nationwide population-based study. Front Neurol 12:611446. https:\/\/doi.org\/10.3389\/fneur.2021.611446","journal-title":"Front Neurol"},{"issue":"1","key":"13899_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01032-5","volume":"14","author":"HG Choi","year":"2022","unstructured":"Choi HG, Kim JH, Kim JH et al (2022) Associations between proton pump inhibitors and Alzheimer\u2019s disease: a nested case-control study using a Korean nationwide health screening cohort. Alzheimers Res Ther 14(1):91. https:\/\/doi.org\/10.1186\/s13195-022-01032-5","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"13899_CR20","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ije\/dys147","volume":"41","author":"JP Vandenbroucke","year":"2012","unstructured":"Vandenbroucke JP, Pearce N (2012) Case-control studies: basic concepts. Int J Epidemiol 41(5):1480\u20131489. https:\/\/doi.org\/10.1093\/ije\/dys147","journal-title":"Int J Epidemiol"},{"issue":"1","key":"13899_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.14283\/jpad.2023.78","volume":"11","author":"JH Hou","year":"2024","unstructured":"Hou JH, Sun SL, Tan CC, Huang YM, Tan L, Xu W (2024) Relationships of hypnotics with incident dementia and Alzheimer\u2019s disease: a longitudinal study and meta-analysis. J Prev Alzheimers Dis 11(1):117\u2013129. https:\/\/doi.org\/10.14283\/jpad.2023.78","journal-title":"J Prev Alzheimers Dis"},{"key":"13899_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jpsychires.2014.07.003","volume":"58","author":"YW Yang","year":"2014","unstructured":"Yang YW, Hsieh TF, Yu CH, Huang YS, Lee CC, Tsai TH (2014) Zolpidem and the risk of Parkinson\u2019s disease: a nationwide population-based study. J Psychiatr Res 58:84\u201388. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.07.003","journal-title":"J Psychiatr Res"},{"issue":"9","key":"13899_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.24124","volume":"4","author":"J Martinkova","year":"2021","unstructured":"Martinkova J, Quevenco FC, Karcher H et al (2021) Proportion of women and reporting of outcomes by sex in clinical trials for Alzheimer disease: a systematic review and meta-analysis. JAMA Netw Open 4(9):e2124124. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.24124","journal-title":"JAMA Netw Open"},{"key":"13899_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pnpbp.2018.05.025","volume":"86","author":"S Wang","year":"2018","unstructured":"Wang S, Mao S, Xiang D, Fang C (2018) Association between depression and the subsequent risk of Parkinson\u2019s disease: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 86:186\u2013192. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.05.025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11","key":"13899_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.42744","volume":"6","author":"W Zhang","year":"2023","unstructured":"Zhang W, Liang J, Li C et al (2023) Age at diagnosis of atrial fibrillation and incident dementia. JAMA Netw Open 6(11):e2342744. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.42744","journal-title":"JAMA Netw Open"},{"issue":"2","key":"13899_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1212\/WNL.0000000000003482","volume":"88","author":"K Deckers","year":"2017","unstructured":"Deckers K, Camerino I, van Boxtel MP et al (2017) Dementia risk in renal dysfunction: a systematic review and meta-analysis of prospective studies. Neurology 88(2):198\u2013208. https:\/\/doi.org\/10.1212\/WNL.0000000000003482","journal-title":"Neurology"},{"issue":"5","key":"13899_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13589","volume":"31","author":"M Guay-Gagnon","year":"2022","unstructured":"Guay-Gagnon M, Vat S, Forget MF et al (2022) Sleep apnea and the risk of dementia: a systematic review and meta-analysis. J Sleep Res 31(5):e13589. https:\/\/doi.org\/10.1111\/jsr.13589","journal-title":"J Sleep Res"},{"issue":"4","key":"13899_CR28","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s13760-023-02209-x","volume":"123","author":"M Balabandian","year":"2023","unstructured":"Balabandian M, Noori M, Lak B, Karimizadeh Z, Nabizadeh F (2023) Traumatic brain injury and risk of Parkinson\u2019s disease: a meta-analysis. Acta Neurol Belg 123(4):1225\u20131239. https:\/\/doi.org\/10.1007\/s13760-023-02209-x","journal-title":"Acta Neurol Belg"},{"issue":"3","key":"13899_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"SV Buuren","year":"2011","unstructured":"Buuren SV, Groothuis-Oudshoorn K (2011) Mice: multivariate imputation by chained equations in R. J Stat Softw 45(3):1\u201367","journal-title":"J Stat Softw"},{"key":"13899_CR30","unstructured":"R Core Team. R: A language and environment for statistical computing. RFoundation for Statistical Computing, Vienna, Austria. 2021. https:\/\/www.R-project.org\/. (Accessed 7 January 2026)"},{"key":"13899_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4856","volume":"372","author":"SV Wang","year":"2021","unstructured":"Wang SV, Pinheiro S, Hua W et al (2021) STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies. BMJ 372:m4856. https:\/\/doi.org\/10.1136\/bmj.m4856","journal-title":"BMJ"},{"key":"13899_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532","volume":"363","author":"SM Langan","year":"2018","unstructured":"Langan SM, Schmidt SA, Wing K et al (2018) The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ 363:k3532. https:\/\/doi.org\/10.1136\/bmj.k3532","journal-title":"BMJ"},{"issue":"10291","key":"13899_CR33","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"8","key":"13899_CR34","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1002\/alz.14057","volume":"20","author":"Y Liang","year":"2024","unstructured":"Liang Y, Liu C, Cheng M et al (2024) The link between gut microbiome and Alzheimer\u2019s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer\u2019s disease. Alzheimers Dement 20(8):5771\u20135788. https:\/\/doi.org\/10.1002\/alz.14057","journal-title":"Alzheimers Dement"},{"issue":"1","key":"13899_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","volume":"56","author":"DO Seo","year":"2024","unstructured":"Seo DO, Holtzman DM (2024) Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. Exp Mol Med 56(1):86\u201394. https:\/\/doi.org\/10.1038\/s12276-023-01146-2","journal-title":"Exp Mol Med"},{"key":"13899_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1149618","volume":"14","author":"R Solanki","year":"2023","unstructured":"Solanki R, Karande A, Ranganathan P (2023) Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration. Front Neurol 14:1149618. https:\/\/doi.org\/10.3389\/fneur.2023.1149618","journal-title":"Front Neurol"},{"issue":"6","key":"13899_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00415-025-13138-5","volume":"272","author":"PJ Oliver","year":"2025","unstructured":"Oliver PJ, Civitelli L, Hu MT (2025) The gut-brain axis in early Parkinson\u2019s disease: from prodrome to prevention. J Neurol 272(6):413. https:\/\/doi.org\/10.1007\/s00415-025-13138-5","journal-title":"J Neurol"},{"key":"13899_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-026-10191-6","author":"TO Cox","year":"2026","unstructured":"Cox TO, Devason AS, de Araujo A et al (2026) Intestinal interoceptive dysfunction drives age-associated cognitive decline. Nature. https:\/\/doi.org\/10.1038\/s41586-026-10191-6","journal-title":"Nature"},{"key":"13899_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1496616","volume":"11","author":"M Alam","year":"2024","unstructured":"Alam M, Abbas K, Mustafa M, Usmani N, Habib S (2024) Microbiome-based therapies for Parkinson\u2019s disease. Front Nutr 11:1496616. https:\/\/doi.org\/10.3389\/fnut.2024.1496616","journal-title":"Front Nutr"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13899-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:09:46Z","timestamp":1781370586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13899-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["13899"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13899-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors NM, MI, and TK declare they have no financial interests. YI was employed with Daiichi Sankyo until December 2024. MN received a lecture fee in the past 24\u00a0months from Ono Pharmaceutical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"349"}}